Network pharmacology of cancer: from understanding of complex interactomes to the design of multi-target specific therapeutics from nature

Poornima Paramasivan, Jothi Dinesh Kumar, Qiaoli Zhao, Martina Blunder, Thomas Efferth

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Despite massive investments in drug research and development, the significant decline in the number of new drugs approved or translated to clinical use raises the question, whether single targeted drug discovery is the right approach. To combat complex systemic diseases that harbour robust biological networks such as cancer, single target intervention is proved to be ineffective. In such cases, network pharmacology approaches are highly useful, because they differ from conventional drug discovery by addressing the ability of drugs to target numerous proteins or networks involved in a disease. Pleiotropic natural products are one of the promising strategies due to their multi-targeting and due to lower side effects. In this review, we discuss the application of network pharmacology for cancer drug discovery. We provide an overview of the current state of knowledge on network pharmacology, focus on different technical approaches and implications for cancer therapy (e.g. polypharmacology and synthetic lethality), and illustrate the therapeutic potential with selected examples green tea polyphenolics, Eleutherococcus senticosus, Rhodiola rosea, and Schisandra chinensis). Finally, we present future perspectives on their plausible applications for diagnosis and therapy of cancer.
Original languageEnglish
Pages (from-to)290-302
Number of pages13
JournalPharmacological Research
Volume111
Early online date18 Jun 2016
DOIs
Publication statusPublished - 30 Sep 2016
Externally publishedYes

Fingerprint

Drug Discovery
Pharmacology
Polypharmacology
Neoplasms
Eleutherococcus
Rhodiola
Schisandra
Pharmaceutical Preparations
Tea
Therapeutics
Biological Products
Research
Proteins

Cite this

@article{b9c650f6741c43e299957681e11bd04d,
title = "Network pharmacology of cancer: from understanding of complex interactomes to the design of multi-target specific therapeutics from nature",
abstract = "Despite massive investments in drug research and development, the significant decline in the number of new drugs approved or translated to clinical use raises the question, whether single targeted drug discovery is the right approach. To combat complex systemic diseases that harbour robust biological networks such as cancer, single target intervention is proved to be ineffective. In such cases, network pharmacology approaches are highly useful, because they differ from conventional drug discovery by addressing the ability of drugs to target numerous proteins or networks involved in a disease. Pleiotropic natural products are one of the promising strategies due to their multi-targeting and due to lower side effects. In this review, we discuss the application of network pharmacology for cancer drug discovery. We provide an overview of the current state of knowledge on network pharmacology, focus on different technical approaches and implications for cancer therapy (e.g. polypharmacology and synthetic lethality), and illustrate the therapeutic potential with selected examples green tea polyphenolics, Eleutherococcus senticosus, Rhodiola rosea, and Schisandra chinensis). Finally, we present future perspectives on their plausible applications for diagnosis and therapy of cancer.",
author = "Poornima Paramasivan and Kumar, {Jothi Dinesh} and Qiaoli Zhao and Martina Blunder and Thomas Efferth",
year = "2016",
month = "9",
day = "30",
doi = "10.1016/j.phrs.2016.06.018",
language = "English",
volume = "111",
pages = "290--302",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

Network pharmacology of cancer : from understanding of complex interactomes to the design of multi-target specific therapeutics from nature. / Paramasivan, Poornima; Kumar, Jothi Dinesh; Zhao, Qiaoli; Blunder, Martina; Efferth, Thomas .

In: Pharmacological Research, Vol. 111, 30.09.2016, p. 290-302.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Network pharmacology of cancer

T2 - from understanding of complex interactomes to the design of multi-target specific therapeutics from nature

AU - Paramasivan, Poornima

AU - Kumar, Jothi Dinesh

AU - Zhao, Qiaoli

AU - Blunder, Martina

AU - Efferth, Thomas

PY - 2016/9/30

Y1 - 2016/9/30

N2 - Despite massive investments in drug research and development, the significant decline in the number of new drugs approved or translated to clinical use raises the question, whether single targeted drug discovery is the right approach. To combat complex systemic diseases that harbour robust biological networks such as cancer, single target intervention is proved to be ineffective. In such cases, network pharmacology approaches are highly useful, because they differ from conventional drug discovery by addressing the ability of drugs to target numerous proteins or networks involved in a disease. Pleiotropic natural products are one of the promising strategies due to their multi-targeting and due to lower side effects. In this review, we discuss the application of network pharmacology for cancer drug discovery. We provide an overview of the current state of knowledge on network pharmacology, focus on different technical approaches and implications for cancer therapy (e.g. polypharmacology and synthetic lethality), and illustrate the therapeutic potential with selected examples green tea polyphenolics, Eleutherococcus senticosus, Rhodiola rosea, and Schisandra chinensis). Finally, we present future perspectives on their plausible applications for diagnosis and therapy of cancer.

AB - Despite massive investments in drug research and development, the significant decline in the number of new drugs approved or translated to clinical use raises the question, whether single targeted drug discovery is the right approach. To combat complex systemic diseases that harbour robust biological networks such as cancer, single target intervention is proved to be ineffective. In such cases, network pharmacology approaches are highly useful, because they differ from conventional drug discovery by addressing the ability of drugs to target numerous proteins or networks involved in a disease. Pleiotropic natural products are one of the promising strategies due to their multi-targeting and due to lower side effects. In this review, we discuss the application of network pharmacology for cancer drug discovery. We provide an overview of the current state of knowledge on network pharmacology, focus on different technical approaches and implications for cancer therapy (e.g. polypharmacology and synthetic lethality), and illustrate the therapeutic potential with selected examples green tea polyphenolics, Eleutherococcus senticosus, Rhodiola rosea, and Schisandra chinensis). Finally, we present future perspectives on their plausible applications for diagnosis and therapy of cancer.

U2 - 10.1016/j.phrs.2016.06.018

DO - 10.1016/j.phrs.2016.06.018

M3 - Article

VL - 111

SP - 290

EP - 302

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -